Brief: WPD Pharmaceuticals Engages Worldwide Clinical Trials As CRO For Further Support On Berubicin Trials
11/02/2021 14:11
Feb 11 (Reuters) - WPD Pharmaceuticals Inc WBIO.CD :
* WPD PHARMACEUTICALS ENGAGES WORLDWIDE CLINICAL TRIALS AS
CRO FOR
FURTHER SUPPORT ON BERUBICIN TRIALS
Source text for Eikon: ID:nGNX7kk1C2
Further company coverage: WBIO.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WPD Pharmaceuticals
See all newsBrief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
Brief: WPD Pharmaceuticals Signs Annex To License Agreement With Wake Forest University Health Sciences
Brief: WPD Pharmaceuticals Announces Proposed Restructuring Of Polish Subsidiary
Brief: WPD Pharmaceuticals Enters Into Amended And Restated Sublicense Agreement With Moleculin Biotech